Abstract

BackgroundAngiopoietin-2 (Ang-2) is associated with lung injury in ALI/ARDS. As endothelial activation by thrombin plays a role in the permeability of acute lung injury and Ang-2 may modulate the kinetics of thrombin-induced permeability by impairing the organization of vascular endothelial (VE-)cadherin, and affecting small Rho GTPases in human pulmonary microvascular endothelial cells (HPMVECs), we hypothesized that Ang-2 acts as a sensitizer of thrombin-induced hyperpermeability of HPMVECs, opposed by Ang-1.Methodology/Principal FindingsPermeability was assessed by measuring macromolecule passage and transendothelial electrical resistance (TEER). Angiopoietins did not affect basal permeability. Nevertheless, they had opposing effects on the thrombin-induced permeability, in particular in the initial phase. Ang-2 enhanced the initial permeability increase (passage, P = 0.010; TEER, P = 0.021) in parallel with impairment of VE-cadherin organization without affecting VE-cadherin Tyr685 phosphorylation or increasing RhoA activity. Ang-2 also increased intercellular gap formation. Ang-1 preincubation increased Rac1 activity, enforced the VE-cadherin organization, reduced the initial thrombin-induced permeability (TEER, P = 0.027), while Rac1 activity simultaneously normalized, and reduced RhoA activity at 15 min thrombin exposure (P = 0.039), but not at earlier time points. The simultaneous presence of Ang-2 largely prevented the effect of Ang-1 on TEER and macromolecule passage.Conclusions/SignificanceAng-1 attenuated thrombin-induced permeability, which involved initial Rac1 activation-enforced cell-cell junctions, and later RhoA inhibition. In addition to antagonizing Ang-1, Ang-2 had also a direct effect itself. Ang-2 sensitized the initial thrombin-induced permeability accompanied by destabilization of VE-cadherin junctions and increased gap formation, in the absence of increased RhoA activity.

Highlights

  • Excessive and sustained activation of the pulmonary endothelium is central in the pathogenesis of the pulmonary inflammation and permeability of the life-threatening syndromes acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) [1]

  • After a second magnetic separation of human pulmonary microvascular endothelial cells (HPMVECs) and non-endothelial cells, the culture showed a purity of .99% as confirmed by the presence of endothelial cell markers vascular endothelial (VE-)cadherin, CD31, von Willebrand factor (VWF), Tie2 and endothelial nitric oxide synthase and the absence of smooth muscle cell (SMC) marker a-actin and epithelial cell marker pancytokeratin

  • Basal effects of angiopoietins Unexpectedly, neither Ang-2, nor Ang-1 affected the basal endothelial barrier function as determined by HRP passage (Figure 1a) or transendothelial electrical resistance (TEER) (Figure 1b). This was found with Ang-1 and 2 concentrations ranging from 5 to 400 ng/ml. To exclude that this was due to the short stimulation period (30 min), HPMVECs were stimulated with Ang-2 for 5 hours

Read more

Summary

Introduction

Excessive and sustained activation of the pulmonary endothelium is central in the pathogenesis of the pulmonary inflammation and permeability of the life-threatening syndromes acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) [1]. ALI/ARDS was not appropriately modeled using those cell types, since endothelial cells from different vascular beds display remarkable heterogeneity in structure and function [22,23,24] It remains to be investigated in an in vitro model of ALI using human pulmonary microvascular endothelial cells (HPMVECs), whether Ang-2 modulates the thrombin-induced permeability and which pathways are involved. As endothelial activation by thrombin plays a role in the permeability of acute lung injury and Ang-2 may modulate the kinetics of thrombin-induced permeability by impairing the organization of vascular endothelial (VE-)cadherin, and affecting small Rho GTPases in human pulmonary microvascular endothelial cells (HPMVECs), we hypothesized that Ang-2 acts as a sensitizer of thrombin-induced hyperpermeability of HPMVECs, opposed by Ang-1

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call